NovoCure Ltd. Files Q1 2026 10-Q Report
Ticker: NVCR · Form: 10-Q · Filed: Apr 30, 2026 · CIK: 0001645113
| Field | Detail |
|---|---|
| Company | Novocure Ltd (NVCR) |
| Form Type | 10-Q |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
NovoCure dropped its Q1 2026 10-Q. Check financials.
AI Summary
NovoCure Ltd. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing includes financial statements and other disclosures relevant to investors. The company's mailing and business address is located at No. 4 The Forum, Grenville Street, St. Helier, Jersey.
Why It Matters
This 10-Q filing provides investors with an update on NovoCure's financial performance and operational status for the first quarter of 2026.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not inherently indicate new or elevated risks.
Key Numbers
- 2026-03-31 — Period End Date (The financial and operational data in the report pertains to this date.)
- 2026-04-30 — Filing Date (The date NovoCure Ltd. officially submitted this 10-Q filing to the SEC.)
Key Players & Entities
- NovoCure Ltd (company) — Filer of the 10-Q report
- 0001645113 (company) — CIK number for NovoCure Ltd
- 2026-03-31 (date) — Period of report for the 10-Q
- 2026-04-30 (date) — Filing date of the 10-Q
- No. 4 The Forum, Grenville Street, St. Helier, Jersey (location) — Mailing and business address of NovoCure Ltd
FAQ
What is the primary document filed by NovoCure Ltd. on April 30, 2026?
NovoCure Ltd. filed a Form 10-Q, which is a quarterly report.
For what period does this 10-Q report provide information?
The report covers the period ending March 31, 2026.
What is NovoCure Ltd.'s CIK number?
NovoCure Ltd.'s CIK number is 0001645113.
Where is NovoCure Ltd.'s business address located?
NovoCure Ltd.'s business address is located at No. 4 The Forum, Grenville Street, St. Helier, Jersey.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001645113-26-000042.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2026 regarding NovoCure Ltd (NVCR).